News and media

Dr Lucas de Toca, COVID-19 Primary Care Response First Assistant Secretary, answers the top 3 questions you’ve been asking on our social accounts.

Have you thought about participating in MRFF grant assessment committees? Read the experiences of our assessors and find out how to nominate.

COVID-19 vaccination information kiosks are now open in shopping centres and events in New South Wales, Queensland, Victoria and Western Australia to help you book a vaccination appointment.

Dr Lucas De Toca, COVID-19 Primary Care Response First Assistant Secretary, answers the Top Three questions across our channels.

A rapid antigen test (RAT) is a quick way to test if you are positive for COVID-19.

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 9 February 2022.

The Australian Government will invest up to $24 million in research to improve acute care systems and reduce emergency department waiting times. Funding is from the Medical Research Future Fund (MRFF).

We have released a concept paper outlining a new, improved approach to regulating aged care.

The Australian Technical Advisory Group on Immunisation (ATAGI) has made recommendations for use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years.

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 2 February 2022.

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 27 January 2022.

COVID-19 vaccination information kiosks are now open in shopping centres and events in South Australia, Western Australia, Victoria, New South Wales and Queensland to help you book a vaccination appointment.

Professor Alison McMillan, Chief Nursing and Midwifery Officer, answers the top three questions across our channels.

Providers must comply with all program requirements, including the schedule of services items and fees. Providers must comply with mandatory state and territory Public Health Orders.

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 19 January 2022.

Novavax COVID-19 vaccine, also known as Nuvaxovid (Biocelect Pty Ltd/Novavax Inc) has been provisionally approved by the Therapeutic Goods Administration (TGA) for use in a primary course of vaccination in people aged 18 years and older.

COVID-19 vaccination information kiosks are now open in shopping centres in New South Wales, Queensland, South Australia, Victoria and Western Australia to help you book a vaccination appointment.